Surufatinib combined with transarterial embolization versus surufatinib monotherapy in patients with liver metastatic neuroendocrine tumors: Study protocol for a prospective, randomized, controlled trial.
Ruizhen LiXiao-Fen LiXin YouMinggang SuYuzhi LiuNeng-Wen KeDan CaoPublished in: Cancer medicine (2024)
This is the first prospective study to investigate the efficacy of surufatinib combined with TAE. We expect this trial to propose a new and effective treatment strategy for liver metastatic NETs.